Literature DB >> 9731184

Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.

K Park1, R B Moreland, I Goldstein, A Atala, A Traish.   

Abstract

Phosphodiesterases play an important physiological role by regulating the intracellular levels of cyclic nucleotides. In this study, we investigated the kinetic parameters of inhibition of phosphodiesterase (PDE) type 5 (EC 3.1.4.35, 3',5'-cyclic GMP phosphodiesterase) by a novel, high-affinity, selective PDE type 5 inhibitor, sildenafil, in intact cells and in soluble extracts of human clitoral corpus cavernosum smooth muscle cells. Sildenafil inhibited cGMP hydrolysis in the crude extract (Ki = 7.2 +/- 2.7) and in partially purified preparations (Ki = 9 nM) in a competitive manner, as determined by Dixon plots. Sildenafil was a more effective PDE type 5 inhibitor than zaprinast (Ki = 400.0 +/- 76.4 nM, crude extracts; 250 nM, partially purified). Stimulation of intracellular cGMP synthesis by the nitric oxide donor sodium nitroprusside resulted in a 3.3- and 2.9-fold increase in cGMP concentration in the presence of sildenafil or zaprinast, respectively, compared to sodium nitroprusside treatment alone in intact cells at physiological temperatures. These observations suggest that human clitoral corpus cavernosum smooth muscle tone may be regulated by the synthesis and release of nitric oxide and that this pathway is dependent on PDE type 5 activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731184     DOI: 10.1006/bbrc.1998.9206

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Sexual side effects of antidepressant drugs.

Authors:  A J Gelenberg; P Delgado; H G Nurnberg
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 2.  Recent advances in female sexual dysfunction.

Authors:  A R Davis
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 3.  Neurogenic female sexual dysfunction: a review.

Authors:  M L Sipski; A Behnegar
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

4.  KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels.

Authors:  Rong-Jyh Lin; Bin-Nan Wu; Yi-Ching Lo; Kuo-Pyng Shen; Young-Tso Lin; Chun-Hsiung Huang; Ing-Jun Chen
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 5.  Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.

Authors:  Stephen L Archer; Ferrante S Gragasin; Linda Webster; Derek Bochinski; Evangelos D Michelakis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Phosphodiesterase inhibitors in female sexual dysfunction.

Authors:  Margit Mayer; Christian G Stief; Michael C Truss; Stefan Uckert
Journal:  World J Urol       Date:  2005-10-25       Impact factor: 4.226

7.  Zaprinast, a phosphodiesterase type-5 inhibitor, alters paced mating behavior in female rats.

Authors:  Ann S Clark; Sarah H Meerts; Fay A Guarraci
Journal:  Physiol Behav       Date:  2008-10-29

8.  Short- and long-term effects of Ginkgo biloba extract on sexual dysfunction in women.

Authors:  Cindy M Meston; Alessandra H Rellini; Michael J Telch
Journal:  Arch Sex Behav       Date:  2008-02-15

9.  Sildenafil citrate in the treatment of pain in primary dysmenorrhea: a randomized controlled trial.

Authors:  R Dmitrovic; A R Kunselman; R S Legro
Journal:  Hum Reprod       Date:  2013-08-06       Impact factor: 6.918

Review 10.  Late-stage clinical development in lower urogenital targets: sexual dysfunction.

Authors:  Usman Azam
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.